Experienced in Transient Ischemic Attack (TIA)

Dr. Barry D. Bertolet

Cardiology | Interventional Cardiology
North Mississippi Clinics LLC
499 Gloster Creek Vlg, Suite A2, 
Tupelo, MS 
Accepting New Patients
Offers Telehealth
Experienced in Transient Ischemic Attack (TIA)
North Mississippi Clinics LLC
499 Gloster Creek Vlg, Suite A2, 
Tupelo, MS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Barry Bertolet is a Cardiologist and an Interventional Cardiologist in Tupelo, Mississippi. Dr. Bertolet is rated as an Experienced provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Lithotripsy, and Percutaneous Coronary Intervention (PCI). Dr. Bertolet is currently accepting new patients.

His clinical research consists of co-authoring 23 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in MS
Hospital Affiliations
North Mississippi Medical Center-Gilmore Amory
Magnolia Regional Health Center
Clay County Medical Corporation
North Mississippi Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

NORTH MISSISSIPPI CLINICS LLC
499 Gloster Creek Vlg, Suite A2, Tupelo, MS 38801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
Enrollment Status: Active_not_recruiting
Publish Date: April 04, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent 48mm Everolimus Eluting Coronary Stent System (EECSS) in Treatment of de Novo Native Coronary Artery Disease
A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent 48mm Everolimus Eluting Coronary Stent System (EECSS) in Treatment of de Novo Native Coronary Artery Disease
Enrollment Status: Completed
Publish Date: January 08, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Device
Study Phase: Not Applicable
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Enrollment Status: Completed
Publish Date: December 20, 2023
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Device
Study Phase: Not Applicable
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Enrollment Status: Unknown
Publish Date: February 16, 2023
Intervention Type: Drug, Device
Study Phase: Phase 3
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Enrollment Status: Terminated
Publish Date: June 28, 2022
Intervention Type: Device
Study Phase: Not Applicable
Multi-center, Prospective, PM Registry for Procedural Outcomes Using the Cardiva VASCADE VCS for Closing the Femoral Arteriotomy After Percutaneous Endovascular Procedures Via Antegrade Access.
Multi-center, Prospective, PM Registry for Procedural Outcomes Using the Cardiva VASCADE VCS for Closing the Femoral Arteriotomy After Percutaneous Endovascular Procedures Via Antegrade Access.
Enrollment Status: Completed
Publish Date: January 18, 2020
Intervention Type: Device
A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension
A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension
Enrollment Status: Terminated
Publish Date: May 13, 2019
Intervention Type: Other, Device
Study Phase: Not Applicable
View 13 Less Clinical Trials

23 Total Publications

Incidence of Cardiac Arrhythmias Identified by Insertable Cardiac Monitors in Patients With Symptomatic Heart Failure.
Incidence of Cardiac Arrhythmias Identified by Insertable Cardiac Monitors in Patients With Symptomatic Heart Failure.
Journal: JACC. Heart failure
Published: March 03, 2025
Similar Doctors
Advanced in Transient Ischemic Attack (TIA)
Dr. Justin A. May
Interventional Cardiology | Emergency Medicine
Advanced in Transient Ischemic Attack (TIA)
Dr. Justin A. May
Interventional Cardiology | Emergency Medicine

Stern Cardiovascular Foundation, Inc

100 Baptist Memorial Cir, Suite 201, 
Oxford, MS 
 (46.8 miles away)
901-271-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Justin May is an Interventional Cardiologist and an Emergency Medicine provider in Oxford, Mississippi. Dr. May is rated as a Distinguished provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Heart Attack, and Pacemaker Implantation. Dr. May is currently accepting new patients.

Advanced in Transient Ischemic Attack (TIA)
Dr. Mark H. Strong
Cardiology
Advanced in Transient Ischemic Attack (TIA)
Dr. Mark H. Strong
Cardiology

Stern Cardiovascular Foundation, Inc

100 Baptist Memorial Cir, Suite 201, 
Oxford, MS 
 (46.8 miles away)
901-271-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Strong is a Cardiologist in Oxford, Mississippi. Dr. Strong is rated as a Distinguished provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Metabolic Syndrome, and Pacemaker Implantation. Dr. Strong is currently accepting new patients.

Advanced in Transient Ischemic Attack (TIA)
Dr. Mark E. Campbell
Interventional Cardiology | Cardiology
Advanced in Transient Ischemic Attack (TIA)
Dr. Mark E. Campbell
Interventional Cardiology | Cardiology

Stern Cardiovascular Foundation, Inc

100 Baptist Memorial Cir, Suite 201, 
Oxford, MS 
 (46.8 miles away)
901-271-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Campbell is an Interventional Cardiologist and a Cardiologist in Oxford, Mississippi. Dr. Campbell is rated as a Distinguished provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Dilated Cardiomyopathy (DCM), and Pacemaker Implantation. Dr. Campbell is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bertolet's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 25 Advanced Conditions
    View All 52 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile